drugset / Trial / NCT02110719

Decreasing Narcotics in Advanced Pelvic Surgery

NCT02110719

Phase 4 Completed 138 enrolled Hartford Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

In recent years, there has been an emphasis on the creation of "enhanced-recovery", "fast-track" or "multi-modal" pathways to improve perioperative care (1-4). The goal of these programs is to reduce the length of hospital stay, decrease narcotic usage while improving pain control, accelerate post-operative recovery, and expedite return to baseline functional status. Pathways often are developed by a team of surgeons, nurses, pain specialists, anesthesiologists and other support staff. Postoperative components often involve multi-modal analgesia, early return to activity and early return to a regular diet. The goal of this study is to evaluate the efficacy of a multi-modal pain regimen in advanced pelvic surgery with a primary goal of decreasing narcotic usage.

Timeline

Start
2014-03
Primary completion
2015-07
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule Intravenous
Comparator Celecoxib Other / unclassified
Comparator Gabapentin Small molecule
Comparator Ibuprofen Small molecule Oral
Comparator Dexamethasone Small molecule
Comparator Hydrocodone Unknown
Comparator Hydromorphone Other / unclassified
Comparator Ondansetron Other / unclassified
Comparator Oxycodone Other / unclassified

Indications